RGEN

#3722
Repligen Corporation - Common Stock
1.2 4 USD
-98.99%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
1.24
1.24
Faixa anual
1.12
175.57
Mudança diária
-98.99%
Mudança mensal
-98.91%
Mudança em 6 meses
-99.26%
Mudança anual
-99.25%
Fechamento anterior
122.7 3
Open
1.2 4
Mínimo
1.2 4
High
1.2 4
Volume
154
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 202020212022202320242025 TTM

Repligen Corporation - Common Stock

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

Notícias